463 research outputs found
Nanosatellite Launch Adapter System (NLAS)
The utility of small spacecraft based on the University cubesat standard is becoming evident as more and more agencies and organizations are launching or planning to include nanosatellites in their mission portfolios. Cubesats are typically launched as secondary spacecraft in enclosed, containerized deployers such as the CalPoly Poly Picosat Orbital Deployer (P-POD) system. The P-POD allows for ease of integration and significantly reduces the risk exposure to the primary spacecraft and mission. NASA/ARC and the Operationally Responsive Space office are collaborating to develop a Nanosatellite Launch Adapter System (NLAS), which can accommodate multiple cubesat or cubesat-derived spacecraft on a single launch vehicle. NLAS is composed of the adapter structure, P-POD or similar spacecraft dispensers, and a sequencer/deployer system. This paper describes the NLAS system and it s future capabilities, and also provides status on the system s development and potential first use in space
Small Rocket/Spacecraft Technology (SMART) Platform
The NASA Goddard Space Flight Center (GSFC) and the Department of Defense Operationally Responsive Space (ORS) Office are exercising a multi-year collaborative agreement focused on a redefinition of the way space missions are designed and implemented. A much faster, leaner and effective approach to space flight requires the concerted effort of a multi-agency team tasked with developing the building blocks, both programmatically and technologically, to ultimately achieve flights within 7-days from mission call-up. For NASA, rapid mission implementations represent an opportunity to find creative ways for reducing mission life-cycle times with the resulting savings in cost. This in tum enables a class of missions catering to a broader audience of science participants, from universities to private and national laboratory researchers. To that end, the SMART (Small Rocket/Spacecraft Technology) micro-spacecraft prototype demonstrates an advanced avionics system with integrated GPS capability, high-speed plug-and-playable interfaces, legacy interfaces, inertial navigation, a modular reconfigurable structure, tunable thermal technology, and a number of instruments for environmental and optical sensing. Although SMART was first launched inside a sounding rocket, it is designed as a free-flyer
Kinetic Resolution in Asymmetric Epoxidation using Iminium Salt Catalysis
The first reported examples of kinetic resolution in epoxidation reactions using iminium salt catalysis are described, providing up to 99% ee in the epoxidation of racemic cis-chromenes
Immune or genetic-mediated disruption of CASPR2 causes pain hypersensitivity due to enhanced primary afferent excitability
Human autoantibodies to contactin-associated protein-like 2 (CASPR2) are often associated with neuropathic pain, and CASPR2 mutations have been linked to autism spectrum disorders, in which sensory dysfunction is increasingly recognized. Human CASPR2 autoantibodies, when injected into mice, were peripherally restricted and resulted in mechanical pain-related hypersensitivity in the absence of neural injury. We therefore investigated the mechanism by which CASPR2 modulates nociceptive function. Mice lacking CASPR2 (Cntnap2 ) demonstrated enhanced pain-related hypersensitivity to noxious mechanical stimuli, heat, and algogens. Both primary afferent excitability and subsequent nociceptive transmission within the dorsal horn were increased in Cntnap2 mice. Either immune or genetic-mediated ablation of CASPR2 enhanced the excitability of DRG neurons in a cell-autonomous fashion through regulation of Kv1 channel expression at the soma membrane. This is the first example of passive transfer of an autoimmune peripheral neuropathic pain disorder and demonstrates that CASPR2 has a key role in regulating cell-intrinsic dorsal root ganglion (DRG) neuron excitability
Possible detection of two giant extrasolar planets orbiting the eclipsing polar UZ Fornacis
We present new high-speed, multi-observatory, multi-instrument photometry of
the eclipsing polar UZ For in order to measure precise mid-eclipse times with
the aim of detecting any orbital period variations. When combined with
published eclipse times and archival data spanning ~27 years, we detect
departures from a linear and quadratic trend of ~60 s. The departures are
strongly suggestive of two cyclic variations of 16(3) and 5.25(25) years. The
two favoured mechanisms to drive the periodicities are either two giant
extrasolar planets as companions to the binary (with minimum masses of
6.3(1.5)M(Jupiter) and 7.7(1.2)M(Jupiter)) or a magnetic cycle mechanism (e.g.
Applegate's mechanism) of the secondary star. Applegate's mechanism would
require the entire radiant energy output of the secondary and would therefore
seem to be the least likely of the two, barring any further refinements in the
effect of magnetic fieilds (e.g. those of Lanza et al.). The two planet model
can provide realistic solutions but it does not quite capture all of the
eclipse times measurements. A highly eccentric orbit for the outer planet would
fit the data nicely, but we find that such a solution would be unstable. It is
also possible that the periodicities are driven by some combination of both
mechanisms. Further observations of this system are encouraged.Comment: 10 pages, 4 figures, 2 table
Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial
First published online 20 September 2011Depressive symptoms may increase the risk of progressing from mild cognitive impairment (MCI) to dementia. Consumption of n-3 PUFA may alleviate both cognitive decline and depression. The aim of the present study was to investigate the benefits of supplementing a diet with n-3 PUFA, DHA and EPA, for depressive symptoms, quality of life (QOL) and cognition in elderly people with MCI. We conducted a 6-month double-blind, randomised controlled trial. A total of fifty people aged >65 years with MCI were allocated to receive a supplement rich in EPA (1·67 g EPA + 0·16 g DHA/d; n 17), DHA (1·55 g DHA + 0·40 g EPA/d; n 18) or the n-6 PUFA linoleic acid (LA; 2·2 g/d; n 15). Treatment allocation was by minimisation based on age, sex and depressive symptoms (Geriatric Depression Scale, GDS). Physiological and cognitive assessments, questionnaires and fatty acid composition of erythrocytes were obtained at baseline and 6 months (completers: n 40; EPA n 13, DHA n 16, LA n 11). Compared with the LA group, GDS scores improved in the EPA (P=0·04) and DHA (P=0·01) groups and verbal fluency (Initial Letter Fluency) in the DHA group (P=0·04). Improved GDS scores were correlated with increased DHA plus EPA (r 0·39, P=0·02). Improved self-reported physical health was associated with increased DHA. There were no treatment effects on other cognitive or QOL parameters. Increased intakes of DHA and EPA benefited mental health in older people with MCI. Increasing n-3 PUFA intakes may reduce depressive symptoms and the risk of progressing to dementia. This needs to be investigated in larger, depressed samples with MCI.Natalie Sinn, Catherine M. Milte, Steven J. Street, Jonathan D. Buckley, Alison M. Coates, John Petkov, and Peter R. C. How
High-throughput in vivo vertebrate screening
We demonstrate a high-throughput platform for cellular-resolution in vivo chemical and genetic screens on zebrafish larvae. The system automatically loads zebrafish from reservoirs or multiwell plates, and positions and rotates them for high-speed confocal imaging and laser manipulation of both superficial and deep organs within 19 s without damage. We performed small-scale test screening of retinal axon guidance mutants and neuronal regeneration assays in combination with femtosecond laser microsurgery.National Institutes of Health (U.S.) (Director’s Innovator Award 1-DP2-OD002989–01)David & Lucile Packard Foundation (Award in Science and Engineering)Alfred P. Sloan Foundation (Award)Broad Institute of MIT and Harvard (Sparc Grant)National Science Foundation (U.S.) (Fellowship)Foxconn (Sponsorship
- …